Tag: Trutino Biosciences

Boehringer Ingelheim to acquire biotech company Trutino Biosciences

Boehringer Ingelheim announced the signing of an option to acquire Trutino Biosciences Inc., a San Diego-based biotech company.   Trutino Biosciences is a pre-clinical stage biotech company dedicated to the discovery and development of next-generation cytokine therapies to treat immuno-oncology and autoimmune diseases. Boehringer Ingelheim is dedicated to a two-pronged research strategy to fight cancers:…